Insider Buying: Innovotech (CVE:IOT) Director Purchases C$10,800.00 in Stock

Innovotech Inc. (CVE:IOT) Director Craig Milne acquired 135,000 shares of the business’s stock in a transaction dated Friday, July 3rd. The shares were bought at an average price of C$0.08 per share, with a total value of C$10,800.00. Following the transaction, the director directly owned 1,733,615 shares in the company, valued at approximately C$138,689.20. The trade was a 8.44% increase in their position.

Innovotech Stock Performance

IOT opened at C$0.07 on Friday. The company has a quick ratio of 5.81, a current ratio of 2.63 and a debt-to-equity ratio of 12.55. The firm has a market cap of C$4.08 million, a PE ratio of -11.02 and a beta of 2.64. The business has a fifty day simple moving average of C$0.12 and a 200-day simple moving average of C$0.19. Innovotech Inc. has a fifty-two week low of C$0.07 and a fifty-two week high of C$0.34.

About Innovotech

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.